IASO Biotherapeutics and Innovent Biologics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress

PLEASANTON, Calif. & NANJING, China--(BUSINESS WIRE)-- #AutoimmuneDiseases--IASO Bio & Innovent Biologics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at the EHA Congress.

Click to view original post